Characteristics | Events/Total | N of studies | Mean/Pooled incidence (%) | 95% CI | I2 (%) | P- value | Publication bias (p- value) |
---|---|---|---|---|---|---|---|
Demographic information | |||||||
 Male | 2305/4218 | 29 | 53.6 | 49.4–57.7 | 50 | < 0.01 | 0.2161 |
 Age (years) | 4300/4300 | 29 | 7.04 | 5.06–9.08 | 99.79 | < 0.01 | < 0.05 |
  < 1 | 602/4176 | 24 | 12.0 | 6.3–18.8 | 92 | < 0.01 | 0.7211 |
 1–4 | 456/3791 | 21 | 14.9 | 10.5–19.6 | 60 | < 0.01 | < 0.05 |
 5–9 | 619/3791 | 21 | 23.2 | 17.7–29.0 | 67 | < 0.01 | < 0.05 |
 10–14 | 960/3791 | 21 | 23.1 | 21.6–24.6 | 42 | 0.02 | 0.2341 |
 15–19 | 1253/3962 | 21 | 5.8 | 0.9–13.3 | 95 | < 0.01 | < 0.05 |
 Comorbidities | 159/927 | 12 | 9.9 | 2.0–21.5 | 94 | < 0.01 | 0.5658 |
Epidemiology | |||||||
 Linkage to Wuhan | 275/465 | 21 | 39.8 | 18.0–63.5 | 95 | < 0.01 | < 0.05 |
 Family cluster | 525/704 | 20 | 81.5 | 71.0–90.3 | 86 | < 0.01 | 0.5347 |
Severity of disease | |||||||
 Mild & Common | 344/347 | 14 | 100.0 | 99.1–100.0 | 0 | 1.00 | 0.4795 |
 Severe | 2/347 | 14 | 0 | 0.0–0.6 | 0 | 1.0 | 0.0968 |
 Critical | 1/347 | 14 | 0 | 0.0–0.5 | 0 | 1.0 | < 0.05 |
Clinical manifestations | |||||||
 Asymptomatic | 248/1726 | 28 | 18.9 | 12.1–26.6 | 86 | < 0.01 | < 0.05 |
 Fever | 941/2017 | 29 | 52.7 | 44.3–62.0 | 87 | < 0.01 | 0.1689 |
 Mild (37.7 °C–38.0 °C) | 72/426 | 14 | 19.2 | 12.0–27.4 | 56 | < 0.01 | 0.0575 |
 Moderate (38.1 °C–39.0 °C) | 95/433 | 15 | 15.5 | 9.0–22.9 | 54 | < 0.01 | 0.0819 |
 High (39.1 °C-) | 44/438 | 15 | 8.2 | 2.8–15.3 | 66 | < 0.01 | 0.5681 |
 Cough | 1035/2017 | 29 | 41.9 | 35.7–48.1 | 72 | < 0.01 | < 0.05 |
 Expectoration | 14/270 | 17 | 1.4 | 0.0–4.1 | 43 | 0.03 | 0.464 |
 Pharyngeal erythema | 105/429 | 17 | 6.0 | 0.0–19.1 | 91 | < 0.01 | < 0.05 |
 Sore throat | 425/1985 | 27 | 5.0 | 0.6–11.8 | 93 | < 0.01 | < 0.05 |
 Rhinorrhea | 455/1827 | 27 | 3.5 | 0.1–9.8 | 93 | < 0.01 | < 0.05 |
 Stuffy nose | 26/592 | 24 | 1.0 | 0.1–2.5 | 46 | < 0.01 | 0.4097 |
 Diarrhea | 98/1021 | 26 | 4.2 | 1.8–7.3 | 45 | < 0.01 | < 0.05 |
 Vomiting | 69/1021 | 26 | 3.5 | 2.1–5.1 | 35 | 0.04 | 0.0632 |
 Tachypnea/dyspnea | 117/1057 | 27 | 2.5 | 1.6–4.8 | 72 | < 0.01 | < 0.05 |
 Fatigue/myalgia | 103/1044 | 25 | 2.7 | 0.3–6.4 | 73 | < 0.01 | < 0.05 |
Laboratory findings | |||||||
 WBC decreased | 86/509 | 20 | 10.6 | 5.4–16.8 | 60 | < 0.01 | 0.1130 |
 WBC increased | 38/302 | 18 | 10.3 | 6.6–14.6 | 0 | 0.62 | 0.6663 |
 L decreased | 56/497 | 19 | 10.8 | 3.9–19.7 | 80 | < 0.01 | 0.131 |
 L increased | 33/182 | 13 | 15.4 | 9.8–21.7 | 43 | 0.05 | 0.7734 |
 ALT increased | 39/405 | 15 | 6.5 | 3.8–9.6 | 43 | 0.04 | 0.3616 |
 AST increased | 58/423 | 14 | 10.9 | 5.0–18.2 | 65 | < 0.01 | 0.7864 |
 LDH increased | 51/183 | 13 | 23.0 | 8.8–38.3 | 79 | < 0.01 | 0.7704 |
 CRP increased | 107/537 | 18 | 12.3 | 5.4–21.0 | 77 | < 0.01 | 0.2760 |
Radiographic evaluation | |||||||
 Normal | 166/501 | 23 | 37.4 | 28.0–47.4 | 77 | < 0.01 | < 0.05 |
 GGO | 169/456 | 19 | 35.7 | 31.0–40.5 | 49 | < 0.01 | 0.6935 |
 Consolidation | 38/224 | 14 | 10.5 | 1.6–23.6 | 80 | < 0.01 | 0.7874 |
 Unilateral compromised | 93/365 | 15 | 28.2 | 19.4–37.8 | 55 | 0.01 | 0.0912 |
 Bilateral compromised | 74/365 | 15 | 21.9 | 10.4–35.5 | 80 | < 0.01 | 0.2329 |
Therapy | |||||||
 Oxygen therapy | 38/480 | 17 | 4.9 | 2.7–7.5 | 22 | 0.2 | 0.2031 |
Antiviral treatmen | |||||||
 Interferon | 140/370 | 15 | 63.0 | 25.5–93.9 | 98 | < 0.01 | < 0.05 |
 Lopinavir-ritonavir | 68/216 | 13 | 26.0 | 11.8–42.7 | 83 | < 0.01 | 0.5968 |
 Ribavirin | 14/216 | 13 | 2.9 | 0.5–6.4 | 46 | 0.03 | 0.8658 |
 Oseltamivir | 40/216 | 13 | 10.5 | 0.5–27.2 | 88 | < 0.01 | 0.755 |
 Arbidor | 35/216 | 13 | 5.9 | 0.0–17.8 | 82 | < 0.01 | 0.1585 |
 Antibiotics | 23/182 | 13 | 11.3 | 1.8–25.4 | 79 | < 0.01 | 0.1121 |
 Corticosteroid | 6/387 | 16 | 0.0 | 0.0–0.4 | 13 | 0.30 | < 0.05 |
 Immunoglobin | 8/381 | 16 | 0.0 | 0.0–0.3 | 55 | < 0.01 | < 0.05 |
 Mechanic ventilation | 6/737 | 23 | 0.0 | 0.0–0.2 | 0 | 1.0 | 0.1143 |
Outcomes | |||||||
 Discharged | 419/553 | 20 | 84.1 | 69.6–95.1 | 92 | < 0.01 | 0.7479 |
 ICU admission | 32/1587 | 28 | 0.1 | 0.0–1.3 | 51 | < 0.01 | 0.1641 |
 Death | 4/4278 | 14 | 0.0 | 0.0–0.0 | 0 | 1 | < 0.05 |